Chain-of-title issues in U.S. patent assignments and licenses: Which core documents should a transferee most need to review in 2026, and what is the most easily overlooked link in due diligence?

Conclusion first: When verifying U.S. patent assignments, the assignee should focus not on the assignment contract itself, but on three documents—the USPTO recordation, the inventor assignment chain, and the inventor oath/declaration. The most easily overlooked step in due diligence is the seemingly inconspicuous "Employment Invention Assignment" in the middle of the chain. Without it, all the preceding documents may be castles in the air.

Why is it that even after signing a transfer contract, the rights may still not be yours?

U.S. patent law has its own logic when it comes to "who owns the patent rights." 35 U.S.C. § 261 provides that patent applications and patent rights may be assigned, but the assignment must be in writing, and to have effect against subsequent assignees and purchasers, it must be recorded with the USPTO. In other words, a contract is only effective between the parties; to assert rights against third parties, recording is required. In practice, we have seen many Chinese buyers holding an English assignment agreement signed by both parties, assuming everything is fine, only to check the USPTO Public Record and find that the recorded assignment still shows the original applicant's name. In that state, if the original rights holder sells the same patent to a third party, or if a creditor seizes it to satisfy a debt, your position will be extremely vulnerable.

What makes it even trickier is that the U.S. patent assignment chain is often not just one link. A U.S. patent filed in 2015 might go through inventor → startup → entity designated by Series A investors → new company after Series B restructuring → seller, and every transfer along the way requires written documentation—miss one link and the chain is broken. We typically advise clients to pull each recorded entry from the USPTO Patent Assignment Search and compare it against the paper documents provided by the seller on a timeline basis. Any date that doesn't match up needs to be questioned.

A USPTO filing record is not the right itself, but without it you'll be in a very passive position.

37 C.F.R. § 3.11 and § 3.21 set out the formal requirements for recordation. Recordation itself does not create rights, but it determines priority. The United States follows a "first to record, first to prevail" logic: when multiple assignees claim the same patent, the party that completes recordation first generally has the advantage. By 2026, the USPTO's electronic recordation system has become quite mature. Submitting an assignment typically yields an electronic receipt within 1–2 business days, fees follow 37 C.F.R. § 1.21(h), and each patent requires its own recordation. We usually remind clients: prepare the recordation materials on the closing day itself—don't wait until weeks after closing to remember. That gap in between is where the risk is greatest.

One more point that's easily overlooked—recordation requires distinguishing between an "assignment" and a "license." An exclusive license can also be recorded under certain conditions, but its legal effect is completely different from that of an assignment. Many cross-border transactions lump the two together in a single contract with vaguely drafted clauses, and ultimately the USPTO record shows an Assignment when the parties' actual intent was merely a License. This kind of ambiguity will be seized upon relentlessly by opposing counsel in litigation.

Wherever the chain of inventors breaks, due diligence must trace it to that link.

Under U.S. patent law, the original rights to a patent belong to the inventors, a fundamental principle established by 35 U.S.C. §§ 111 and 115. For a company to obtain those rights, it must secure a written assignment from each inventor. The problem arises when a patent lists four inventors, one of whom is an outside consultant, one a former employee, and one an engineer at an overseas subsidiary. The assignment documents for these three types of people are often not kept in the same HR file, making them the easiest to overlook during due diligence. We generally advise clients to verify each inventor individually: Is there a signature? Is the signing date earlier than the filing date? Is there consideration? Under U.S. law, consideration is not a necessary condition for an assignment to be effective, but an assignment lacking consideration is vulnerable to challenge in subsequent disputes.

If it turns out that an inventor did not sign, there are two paths for obtaining a belated signature: first, go directly to the inventor to obtain the signature (fastest if the person is still available and willing to cooperate); second, use the "substitute statement" procedure under 37 C.F.R. § 1.47, explaining to the USPTO that reasonable efforts were made but the signature could not be obtained. The latter takes longer and requires submitting evidence. Such issues remain highly frequent in cross-border transactions in 2026, especially for teams that conducted R&D in China or India early on and only later filed for patents in the United States.

Inventor oath and ADS: If the names don't match, it's a hidden risk.

The inventor oath or declaration and the Application Data Sheet (ADS) submitted at filing must be consistent with the inventor information in the chain of assignment. In practice, a common situation is: the ADS shows the pinyin name, while the assignment agreement shows the English name as it appears in the passport, with a one-letter difference between them, and the USPTO may then issue a Notice of Incomplete Application. Such formal defects can be corrected, but if they are discovered during the assignment due diligence stage, they will make the buyer question the rigor of the entire chain.

Additionally, if a patent has undergone a reissue or reexamination, the inventor information may change, and the chain of title must be updated accordingly. This is something many buyers encounter for the first time and find confusing—they thought they were buying the original patent, so why is there suddenly a Reissue version? The answer is that a reissue patent replaces the original patent, and the scope of rights may be broader or narrower. The assignment documents must cover the reissued patent number; otherwise, what you've bought may just be a historical record.

Licenses, pledges, and litigation encumbrances: rights defects hidden in the annexes.

Due diligence for an assignment cannot rely solely on the assignment documents; it must also examine whether the target patent has been licensed out, whether it has been pledged, and whether there are ongoing litigation or TTAB (Trademark Trial and Appeal Board) proceedings—although the TTAB mainly handles trademarks, patent-related PTAB (Patent Trial and Appeal Board) proceedings likewise affect the stability of rights. If an exclusive license has been recorded, the buyer, even after obtaining the assignment, remains bound by that license. Non-exclusive licenses are usually not recorded, but if the contract states "irrevocable," it likewise constitutes an encumbrance.

A security interest in the United States can be registered through a UCC-1 financing statement, which is a separate system from USPTO filings. We generally recommend that clients check both the USPTO Assignment Search and the UCC filings in the seller's state; only if both are clean can it be considered clean. This step is often skipped in cross-border transactions because Chinese buyers are unfamiliar with the UCC system of U.S. state law. For supporting services related to intellectual property transactions in the United States and the European Union, please refer toUS and EU Intellectual Property Practice.

2026 Transferee Due Diligence Checklist: Six Documents, Not One Can Be Missed

Consolidate the above logic into an actionable checklist: First, USPTO recordation records (Patent Assignment Search screenshots + recordation receipts); second, the complete chain of assignment documents (from the original inventor to the current seller, corresponding link by link); third, the IP clauses in employment invention assignment agreements or consultant agreements; fourth, the inventor declaration and the ADS inventor information verification checklist; fifth, a search report on licenses, security interests, and litigation encumbrances (including UCC searches); sixth, the seller's representations and warranties regarding ownership. Of these six, the third is the most easily overlooked step in due diligence, because it is usually not in the patent file, but in the HR or legal department's contract repository.

In terms of timing, we generally recommend that clients initiate the transfer due diligence 4–6 weeks before closing, to leave a buffer for re-signing and recordation. The USPTO recordation itself is quick, but re-signing an employment agreement from ten years ago may require tracking down former employees and negotiating consideration, which can easily drag on for weeks. If the target patent is involved in an inter partes review (IPR) before the PTAB, the risk of the claims being invalidated must also be assessed separately, as this directly affects the transfer consideration. For more background on overseas intellectual property transactions, see Overseas Intellectual Property.

In cross-border transactions, assignments and licenses are often discussed together interchangeably.

Chinese companies expanding overseas that engage in patent transactions in the United States commonly use an "Assignment and License-back" structure. The seller assigns the patent to you, and you simultaneously grant the seller a non-exclusive license so that it can continue to use the patent in certain fields. This structure itself is not problematic, but the documents must clearly state: are all rights being assigned or only some rights? What is the scope, term, and territory of the license-back, and may it be sublicensed? If these terms are mentioned only in a single sentence in the main contract, disputes are very likely to arise later. U.S. courts tend to interpret license scope in a textualist manner, so if it is not clearly written, it will be interpreted in a way favorable to the seller, which runs counter to the intuition of many Chinese clients.

Also, if a transaction involves multiple jurisdictions—for example, if the same patent family has US, EU, and Japanese versions—the assignment document for the US portion does not automatically cover the other jurisdictions. The EU and Japan each have their own registration requirements and must be handled separately. For this type of cross-jurisdictional transaction, we generally recommend that clients split the work into separate workflows by jurisdiction, rather than trying to use a single global assignment agreement to cover everything. The intellectual property legal services for other countries include registration process descriptions for different jurisdictions, which can serve as a starting point.

Don't let go after filing: annual fees, maintenance fees, and changes of right holder.

Completing the assignment and receiving the recordation receipt does not mean the matter is over. US patents require maintenance fees to be paid on time, at three points: 3.5 years, 7.5 years, and 11.5 years after grant. There is a 6-month grace period for late payment, but the grace period fees are not cheap. If the assignee's entity name changes after the assignment (for example, due to a company name change or acquisition), the owner on the USPTO record must also be updated accordingly; otherwise, subsequent maintenance fee notices and service of process in litigation may run into problems. In practice, we have seen cases where a patent was mistakenly deemed abandoned because the entity name was not updated. Although it can be rescued through the Revival procedure, the time and fees involved are additional costs.

By 2026, the USPTO's electronic reminder system can already be linked to an email address, but the system only recognizes the rights holder's email registered at the time of filing. The first thing to do after the transfer is completed is to update the contact information under the buyer's entity name. This step takes only a few minutes, but it can save a lot of trouble later on.

The foreign-related intellectual property team at Guangdong Zhiming Law Firm has long handled trademark, patent, and copyright applications and transactions in the United States, the European Union, and many other countries. If you need assistance verifying a U.S. patent assignment chain or drafting cross-border intellectual property transaction documents, please call our hotline at 4008-363-555.

Disclaimer: This article provides general legal information only and does not constitute legal advice for any specific transaction. U.S. patent assignments and licensing involve multiple issues under federal law, state law, and contract interpretation, and specific cases should be evaluated separately based on the relevant documents and facts.